Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy Medical Devices medical-devices

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 18 days ago STAT+: Pharmalittle: We’re reading about doctors powering telehealth GLP-1 scripts, an FDA hold on a Novavax shot, and more - 26 days ago STAT+: FDA agrees to review a rare disease drug that its developer was about to give up on - 7 months ago STAT+: FDA is still struggling to inspect clinical research sites, watchdog finds - 8 months ago STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency - 9 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 10 months ago STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers - 10 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 10 months ago STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors - 11 months ago STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices - 11 months ago Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents - 11 months ago STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds - 11 months ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - 12 months ago STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds - 12 months ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - about 1 year ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - about 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - about 1 year ago
2	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 18 days ago STAT+: Another suit filed against FDA over lab-developed test rule - 3 months ago STAT+: FDA warns medical device makers about rise in fabricated data - 9 months ago
3	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 18 days ago STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound - 9 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 22 days ago 3 FDA approval dates to watch in the year’s final push - 2 months ago FDA’s platform designation aims to ease R&D pain points - 5 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 9 months ago FDA inches closer to defining its regulatory role in AI - 9 months ago
5	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 2 months ago
6	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA warns 2 Chinese labs for oversight failures, animal care violations - 2 months ago FDA’s plan to expand device surveillance faces challenges, GAO finds - 3 months ago FDA sends 2 warning letters after inspecting Chinese syringe manufacturers - 4 months ago FDA creates communication ‘super office’ at CDRH - 4 months ago House committee tells FDA to suspend lab developed test rule - 4 months ago FDA finalizes guidance on studying opioid use disorder treatments - 4 months ago FDA to expand total product life cycle program - 4 months ago FDA expands import alert to block all plastic syringes from Chinese manufacturer - 7 months ago FDA seeks feedback on expansion of premarket cybersecurity guidance - 8 months ago FDA warns industry of ‘fraudulent’ third-party data in device applications - 9 months ago FDA creates ‘super office’ to oversee device cybersecurity, digital health and supply chain - 10 months ago FDA authorizes record number of new devices in 2023 - 10 months ago FDA acts on industry call for clarity about scope of device shortage reporting rules - 12 months ago Acon receives first FDA clearance for over-the-counter COVID-19 antigen test - about 1 year ago FDA finalizes COVID-era guidance, extending flexibility for some remote monitoring devices - about 1 year ago FDA expands total product life cycle program to cover neurological devices - about 1 year ago FDA shares draft medical device harmonization plan to meet MDUFA V goal - about 1 year ago FDA releases draft guidance for studying weight loss devices - about 1 year ago FDA finalizes breakthrough device changes to target health inequities - about 1 year ago House committee tells FDA to suspend lab developed test rule - 4 months ago
7	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	STAT+: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over Elevidys - 2 months ago
8	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays - 2 months ago
9	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This Is Massive News for Eli Lilly Investors - 5 months ago
10	Elise Reuter MedTech Dive Reporter @MedTechDive. Covers medical devices. medical technologydigital therapeutics	FDA official sets out approach to AI in medical devices - 5 months ago FDA drafts guidance outlining real-world evidence for medical device submissions - 11 months ago FDA withdraws from Global Harmonization Working Party - 12 months ago

Journalists covering FDA